Natural killer receptor ligand expression on acute myeloid leukemia impacts survival and relapse after chemotherapy.

Mastaglio, Sara; Wong, Eric; Perera, Travis; Ripley, Jane; Blombery, Piers; Smyth, Mark J; Koldej, Rachel; Ritchie, David

Mastaglio, Sara; Wong, Eric; Perera, Travis; Ripley, Jane; Blombery, Piers; Smyth, Mark J; Koldej, Rachel; Ritchie, David.

Affiliation

Mastaglio S; Department of Clinical Hematology and Bone Marrow Transplantation and.
Wong E; Department of Clinical Hematology and Bone Marrow Transplantation and.
Perera T; Australian Cancer Research Foundation Translational Research Laboratory, Royal Melbourne Hospital, Melbourne, VIC, Australia.
Ripley J; Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.
Blombery P; Department of Clinical Hematology and Bone Marrow Transplantation and.
Smyth MJ; Australian Cancer Research Foundation Translational Research Laboratory, Royal Melbourne Hospital, Melbourne, VIC, Australia.
Koldej R; Australian Cancer Research Foundation Translational Research Laboratory, Royal Melbourne Hospital, Melbourne, VIC, Australia.
Ritchie D; Molecular Hematology Laboratory, Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.

Blood Adv ; 2(4): 335-346, 2018 02 27.

Article de En | MEDLINE | ID: mdl-29449224

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie aigüe myéloïde / Récepteurs de cellules tueuses naturelles / Ligands Limites: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: Blood Adv Année: 2018 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google